GlassScriptPhysician profile
Heide H Moeling
NPI 1831172360
$1,209.34
in general payments reported to CMS, 2019-2025
20 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $107 · 2021: $24.69 · 2022: $135 · 2023: $169 · 2024: $191 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.99 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $272.64 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $163.89 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $100.46 | 2024-2025 | Gemtesa, Myfembree |
| Radius Health, INC. | $97.83 | 2019-2020 | |
| Boston Scientific Corporation | $79.46 | 2019-2025 | Axonics, Upsylon |
| Amgen INC. | $69.57 | 2019-2020 | |
| Hologic Sales and Service, LLC | $63.45 | 2019-2025 | Myosure Tissue Removal Device |
| Organon LLC | $54.36 | 2024-2025 | Jada System |
| Roche Diagnostics Corporation | $39.88 | 2019 | |
| Mayne Pharma Commercial LLC | $39.14 | 2022-2025 | |
| Pfizer INC. | $35.04 | 2023-2024 | |
| Exeltis, USA INC. | $33.94 | 2022 | |
| Biogen, INC. | $26.18 | 2024 | |
| Millicent US INC | $23.60 | 2019 | |
| Abbott Laboratories | $22.00 | 2025 | Proclaim |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $20.00 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Meditrina | $19.59 | 2024 | |
| Therapeuticsmd, INC. | $17.64 | 2020 | |
| Coopersurgical, INC. | $15.74 | 2025 | Sos |
| Evofem Biosciences, INC. | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heide Moeling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.